Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro KwikPen comes with its own built-in needle — covered, pre-attached and ready to use. Each pen contains four weekly doses, and a new needle deploys automatically with each injection, so you do not need to source separate needles the way you might with older insulin pens. That said, many people starting treatment have questions about needle size, changing technique, and what to do with used sharps. This page answers those questions in full, using the prescribing information and NHS clinical guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes. Unlike some injectable medicines where you click on a separate needle cap before each dose, the KwikPen integrates the needle system within the device. When you press the button to inject, the needle extends, delivers the dose, and then automatically retracts back into the pen body. A locking mechanism prevents reuse of the same needle position, which protects against accidental needlestick injuries after the dose is given.
This design means the vast majority of people using Mounjaro will never need to buy or attach separate pen needles. If you have seen general guidance about needles for Mounjaro KwikPen written for older autoinjector formats, it may not apply to the current KwikPen device. The KwikPen itself is the format in which all UK strengths of tirzepatide are supplied, from the 2.5 mg starter through to 15 mg. When your box arrives via DPD in plain, unbranded packaging, you will find the pen and your Patient Information Leaflet inside; the leaflet's illustrated injection steps are the definitive guide to technique, and your prescriber is the right person to answer device questions specific to your situation.
The NHS tirzepatide medicines page provides an accessible summary of how the medicine is administered and what to do if you have concerns about a particular dose.
The KwikPen's needle is factory-fitted at a gauge and length chosen by Eli Lilly to optimise subcutaneous (under-the-skin) delivery in the majority of adults. Subcutaneous injections are designed to reach the fatty tissue layer just beneath the skin, not the muscle below it. The needle is short by the standards of older injectables, this is intentional, and the pinching-up technique some people learnt with earlier medicines is generally not required.
Because the needle is integrated rather than interchangeable, you cannot swap it for a different gauge the way you could with a traditional vial-and-pen setup. If you have a clinical reason for needing a different delivery format (for example, a skin condition affecting the usual sites, or very limited subcutaneous tissue) that is a conversation to have with your prescriber before starting or continuing treatment. Questions about Mounjaro injection pen needles in the UK more broadly, including gauge comparisons, are covered in our related guidance.
For readers who have previously used a different injectable and are used to attaching 4 mm needles for the KwikPen, it is worth confirming with your prescriber or pharmacist that the current KwikPen presentation does not require this step, device specifications have evolved, and the SmPC on the Electronic Medicines Compendium (eMC) holds the definitive technical detail.
A spent KwikPen (or any pen where that week's dose has been administered) is a sharps item. UK regulations and NHS guidance are clear: sharps must not go into household recycling, food waste, or general rubbish bags. The retracted, locked needle inside the pen still constitutes a sharps risk if the device is crushed or damaged in waste processing.
The correct route is a yellow-lidded sharps container, available from most GP surgeries and community pharmacies, and in some areas collected kerbside through your local council. Your GP practice or community pharmacy can advise on the collection scheme in your area. A 1-litre sharps container is a practical size for home use. Dispose of the whole pen, do not attempt to dismantle it. Fill the container only to the marked fill line, then seal and return it via the appropriate route rather than placing it in any domestic bin.
One practical detail worth knowing: the pen should also be disposed of promptly after use, not left in a bag or coat pocket where it could be picked up by a child or a person who does not know what it is. Treating each used pen with the same care as a used syringe is the right habit from the first dose. The Mounjaro injection guide on this site covers broader administration technique, and more detail on the full Mounjaro treatment overview (including eligibility and the clinical assessment process) is available if you are considering whether this medicine might be right for you.
If you are at an earlier stage and exploring weight-loss treatment options more generally, a free consultation with one of our prescribers is the sensible next step. Mounjaro is a prescription-only medicine; a clinician reviews your health picture before any treatment is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.